Scribd Logo
Upload

Welcome to Scribd!

  • 41 views

    TM Presentation Lalmonirhat A 0723

    Uploaded by

    lurtuzolmi

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    TM Presentation Lalmonirhat A 0723

    Uploaded by

    lurtuzolmi
    41 views10 pages

    Original Title

    Tm Presentation Lalmonirhat a 0723

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    41 views10 pages

    TM Presentation Lalmonirhat A 0723

    Uploaded by

    lurtuzolmi

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    You are on page 1of 10

    Performance Analysis of TM

    Territory Name: Lalmonirhat A


    Individual Market performance- July’ 2023

    Market Name Target Amount Cumulative Net Sale Deficit Value Ach.(%)

    Hatibandha A 7.81 lac 7.88 lac + 0.94 113.64%


    Kaligonj Lal A 11.41 lac 11.81 lac + 1.94 119.67%
    Patgram A 12.10 lac 9.74 lac + 0.13 101.38%
    Lalmonirhat A 19.36 lac 19.81 lac + 1.30 107.03%
    Territory 50,69 lac 49.26 lac 4.32 Lac 109.62 %

    ** Please mention bottom 02 market data at the highlighted row


    Top 25 products performance analysis
    Sl no. Product name Unit target Unit sale Unit Ach.(%)
    Ambrox Syp 100ml T 2124 1397 65.77%
    01
    Asynta Max Susp 200ml 438 403 92.01%
    02
    Avaspray N-Spray 248 297 119.76%
    03 120sprays
    Cef-3 200 Cap 14's 544 597 109.74%
    04
    Cef-3 DS Cap 14's 195 164 84.10%
    05
    Cef-3 PFS 30ml 606 859 141.75%
    06
    Cef-3 PFS 50ml 556 729 131.12%
    07
    Cefotil 500 Tab 12's 71 73 102.82%
    08
    Cefotil Plus 250 Tab 12's 677 603 89.07%
    09
    Cefotil Plus 500 Tab 12's 256 252 98.44%
    10
    Ceftron 1g IV Inj 520 630 121.15%
    11
    Ceftron 2g IV Inj 255 336 131.76%
    12
    Top 25 products performance analysis
    Sl no. Product name Unit target Unit sale 13/25 Unit Ach.(%)
    Entacyd Plus Tab 200's 274 244 89.05%
    13
    Filwel Gold Tab 30's 518 390 75.29%
    14
    Filwel Silver Tab 30's 255 227 89.02%
    15
    Flexi Tab 100's 297 301 101.35%
    16
    Folita 5 Tab 30's 244 291 119.26%
    17
    Mirakof Syp 100ml 592 393 66.39%
    18
    Norvis Tab 50's 170 223 131.18%
    19
    Ocof Syp 100ml 1094 399 36.47%
    20
    Tory 120 Tab 30's 374 259 69.25%
    21
    Tory 90 Tab 30's 398 421 105.78%
    22
    Tusca Plus Syp 100ml 1904 906 47.58%
    23
    Volinac Gel 50g 1316 1565 118.92%
    24
    Zif CI Cap 60's 353 365 103.40%
    25
    Causes of poor performance and measures taken
    Bottom 01: Cause:
    1. Lost market leadership.
    Patgram A 2. Smpo generating less than 30 Rx per day
    3. Campaign doctor committed daily Rx not ensured
    4. Donation doctor committed share not ensured.

    Taken Measure:
    1. Ensure regain leadership within half month share of August’ 23.
    2. Gave him guidelines & now he is generating more than 30 Rx per day.
    3. Ensure spot taken from donation doctor chamber.
    4. Ensure committed daily Rx from campaign doctors.
    Cause :
    Bottom 02: 1. Less share from donation doctor.
    Lalmonirhat A 2. Campaign doctor committed daily Rx not ensured
    3. Less capable of taking physical stresss .

    Taken Measure:
    1. Ensured spot taken & committed share from donation doctor.
    2. Ensure committed daily Rx from campaign doctors.
    3. Gave him motivation & ensured doctor consultation. .
    Action plan for further development

    Bottom 02: Lalmonirhat A


    @ Ensure visit of evening consultant at Sadar hospital & UHC.
    @ Ensure 02 hour extra work to achive target ethically.
    @ Regular monitoring of top 25 doctor, party & products.
    @ Daily monitoring of required Rx from campaign & donation doctor.
    @ Ensure 20 discharge per colleague per day

    Bottom 01: Patgram A


    @ Ensure all promotional items, sample, gifts must go to doctors front only.
    @ Arrange migratory fest , snacks, lunch, dinner ensure GP Rx.
    @ Ensure 80% party coverage within 2nd week & 90% within end of the month.
    @ Ensure spot taken from high transaction doctor.
    @ Motivate colleague to be more involved in market rather than run after donation.
    Monitoring information of TM

    Visit in bottom market


    Market Name Market 01 Patgram A Market 02 Lalmonirhat A
    Observation Smpo less aggressive. Frustrated Smpo less capable of taking
    due to not getting incentive . physical stress.

    Physical Stock Check status


    Market Name Market 01 Lalmonirhat A Market 02 Patgram A Market 03 Kaligonj lal A
    Findings 04cc sample short , 2cc Sample distribution not 01cc sample extra found. 01cc
    sample extra found. homogenous. Samples not car umbrella gift on Asynta max
    devided in 04 week. not received.

    Product discussion session outcome


    Product discussed Product 01 Product 02 Product 03
    Result of Exam 28 out of 30 marks
    Monitoring information of TM

    Consignment check status


    Market name Market 01 Lalmonirhat A Market 02 Hatibandha A
    Findings Regular business found Regular business found

    Outcome of Campaign doctors


    Invested/Campaign Commitment Provided share in Justification (if any)
    doctor name last month
    Dr. Md, Abdul baset 17% 24.16%
    Dr. Bipul chandra sarker 17% 19.58%
    Dr. P. K. Das 20% 15.82% Smpo couldn’t document share.
    Business opportunity find out by TM:

    @ Dr. Halima Diabetic hospital, lalmonirhat sadar, 02 physiotherapist doctor visit gap found
    by all SBU.
    Scope of VOLINAC gel & Flamfix .

    1.Dr. Abdul alim


    2.Dr. Golam rabbani

    Now all SBU visit regularly.


    Thanks

    You might also like